Pharmacological options with established evidence include acamprosate, naltrexone, and disulfiram for maintaining abstinence
Your patient will have confidence and safety in your expertise when you recommend this therapy to them in your clinic
The transition is smooth and the human agents are responsive
Notably, a Medicare GLP-1 Bridge pilot begins July 1, 2026 with a $50 monthly copay for eligible enrollees a change from the old rule that Medicare never covered weight loss drugs
Its primary role is maintaining the integrity of the gut barrier by feeding on mucin (the protein that forms intestinal mucus) and, in doing so, stimulating the body to produce more of it
Our robust healthcare practice, which encompasses a significant portion of our total premium, uniquely positions us to address the complexities of this exposure effectively